4.3 Review

Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review

期刊

CURRENT STEM CELL RESEARCH & THERAPY
卷 16, 期 5, 页码 535-550

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574888X16666201221151512

关键词

Mesenchymal stem cells; dental pulp stem cells; SHED; secretome; exosome; Parkinson's disease

资金

  1. Indian Council for Medical Research (ICMR), Government of India, New Delhi [2019-2697/SCR/Adhoc/BMS]

向作者/读者索取更多资源

This review discusses the potential therapeutic role of stem cells derived from human dental pulp tissue (SHED) in neurodegenerative diseases. SHED has several advantages but also some limitations, which require further research and improvement.
Most conventional treatments for neurodegenerative diseases fail due to their focus on neuroprotection rather than neurorestoration. Stem cell-based therapies are becoming a potential treatment option for neurodegenerative diseases as they can home in, engraft, differentiate and produce factors for CNS recovery. Stem cells derived from human dental pulp tissue differ from other sources of mesenchymal stem cells due to their embryonic neural crest origin and neurotrophic property. These include both Dental Pulp Stem Cells (DPSCs) from dental pulp tissues of human permanent teeth and Stem cells from Human Exfoliated Deciduous teeth (SHED). SHED offers many advantages over other types of MSCs, such as good proliferative potential, minimal invasive procurement, neuronal differentiation and neurotrophic capacity, and negligible ethical concerns. The therapeutic potential of SHED is attributed to the paracrine action of extracellularly released secreted factors, specifically the secretome, of which exosomes are a key component. SHED and its conditioned media can be effective in neurodegeneration through multiple mechanisms, including cell replacement, paracrine effects, angiogenesis, synaptogenesis, immunomodulation, and apoptosis inhibition, and SHED exosomes offer an ideal refined bed-to-bench formulation in neurodegenerative disorders. However, in spite of these advantages, there are still some limitations of SHED exosome therapy, such as the effectiveness of long-term storage of SHED and their exosomes, the development of a robust GMP-grade manufacturing protocol, optimization of the route of administration, and evaluation of the efficacy and safety in humans. In this review, we have addressed the isolation, collection and properties of SHED along with its therapeutic potential on in vitro and in vivo neuronal disorder models as evident from the published literature.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据